Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells

Anticancer Research

Volumn 26, Issue 6 B, 2006, Pages 4163-4170

  Vashishta, Aruna ^a   Ohri, Sujata Saraswat ^a   Proctor, Mary ^b,c   Fusek, Martin ^d   Vetvicka, Vaclav ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Activation peptide; Invasion; Lung cancer; Procathepsin D; Proliferation

Indexed keywords

CATHEPSIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENICITY; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; LUNG CANCER; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

CATHEPSIN D; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME PRECURSORS; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33845922054     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schwartz AG and Ruckdeschel JC: Familial Lung Cancer: Genetic Susceptibility and Relationship to COPD. Am J Respir Crit Care Med 173: 16-22, 2006.
2. Goldfarb RH: Proteolytic enzymes in tumor invasion and degradation of host extracellular matrices. In: Mechanisms of Cancer Metastasis. Honn KV, Powers WE and Sloane BF (eds.). Boston, Martinus Nijhoff Publ, pp. 341-375, 1986.
3. Poole AR, Tiltman KJ, Recklies AD and Stoker TA: Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature 273: 545-547, 1978.
4. Gal S and Gottesman MM: The major excreted protein of transformed fibroblasts is an activable acid-protease. J Biol Chem 261: 1760-1765, 1986.
5. Rochefort H, Capony F, Garcia M, Cavailles V, Freiss G, Chambon M, Morisset M and Vignon F: Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem 35: 17-29, 1987.
6. Puri J and Factorovich Y: Selective inhibition of antigen presentation to cloned T cells by protease inhibitors. J Immunol 141: 3313-3317, 1988.
7. Diment S, Martin KJ and Stahl PD: Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. J Biol Chem 264: 13403-13406, 1989.
8. Leto G, Tumminello FM, Crescimanno M, Flandina C and Gebbia N: Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis 21: 91-106, 2004.
9. Rochefort H and Liaudet-Coopman E: Cathepsin D in cancer metastasis: a protease and a ligand. APMIS 107: 86-95, 1999.
10. Brouillet JP, Dufour F, Lemamy G, Garcia M, Schlup N, Grenier J, Mani JC and Rochefort H: Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay. Cancer 79: 2132-2136, 1997.
11. Tandon AK, Clark GM, Chamness GC, Chirgwin JM and McGuirre WL: Cathepsin D and prognosis in breast cancer. N Engl J Med 322: 297-302, 1990.
12. Foekens JA, Look MP, Bolt-de Vries J, Meijer-van Gelder ME, van Putten WL and Klijn JG: Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer 79: 300-307, 1999.
13. Richo G and Conner GE: Structural requirements of procathepsin D activation and maturation. J Biol Chem 269: 14806-14812, 1994.
14. Vignon F, Capony F, Chambon M, Freiss G, Garcia M and Rochefort H: Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology 118: 1537-1545, 1986.
15. Vetvicka V, Vetvickova J and Fusek M: Effect of human procathepsin D on proliferation of human cell lines. Cancer Lett 79: 131-135, 1994.
16. Vetvicka V, Vetvickova J and Fusek M: Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development. Breast Cancer Res Treat 57: 261-269, 1999.
17. Garcia M, Dercoq D, Pujol P and Rochefort H: Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5: 1809-1814, 1990.
18. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M and Liaudet-Coopman E: Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21: 5951-5955, 2002.
19. Fusek M and Vetvicka V: Mitogenic function of human procathepsin D: the role of the propeptide. Biochem J 303: 775-780, 1994.
20. Vetvicka V, Vetvickova J, Hilgert I, Voburka Z and Fusek M: Analysis of the interaction of procathepsin D activation peptide with breast cancer cells. Int J Cancer 73: 403-409, 1997.
21. Benes P, Vashishta A, Saraswat-Ohri S, Fusek M, Pospisilova S, Tichy B and Vetvicka V: Effect of procathepsin D activation peptide on gene expression of breast cancer cells. Cancer Lett 239: 46-54, 2006.
22. Fortenberry SC and Chirgwin JM: The propeptide is nonessential for the expression of human cathepsin D. J Biol Chem 270: 9778-9782, 1995.
23. Vetvicka V, Vetvickova J and Benes P: Role of enzymatically inactive procathepsin D in lung cancer. Anticancer Res 24: 2739-2743, 2004.
24. Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, Basolo F, Pingitore R and Bevilacqua G: Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol 174: 23-31, 1994.
25. Wang Z and Zhao X: Expression and prognostic relation of cathepsin D in non-small cell lung cancer tissues and lymph nodes. Zhonghua Jie He He Hu Xi Za Zhi 21: 164-166, 1998.
26. Higashiyama M, Doi O, Kodama K, Yokouchi H, Kasugai T and Ishiguro S: Influence of cathepsin D expression in lung adenocarcinoma on prognosis: possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells. J Surg Oncol 65: 10-19, 1997.
27. Chyczewski L, Plonski A, Chyczewska E, Furman M, Ostrowska H, Niklinski J and Kozlowski M: Activity and tissue localization of cathepsin D in non small cell lung cancer. Rocz Akad Med Bialymst 42: 217-229, 1997.
28. Vetvicka V, Vetvickova J and Fusek M: Role of procathepsin D activation peptide in prostate cancer growth. Prostate 44: 1-7, 2000.
29. Couissi D, Dubois V, Remacle C, Sohonne E and Trouet A: Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17β-estradiol, tamoxifen and ICI 182,780. Clin Exp Metastasis 15: 349-360, 1997.
30. Amit S and Ben-Neriah Y: NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach. Semin. Cancer Biol 13: 15-28, 2003.
31. Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP and Bours V: Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11: 1835-1841, 1995.